<DOC>
	<DOC>NCT01314482</DOC>
	<brief_summary>In about half the patients who have an open chest surgery there is persistent severe pain in the chest. The investigators are examining whether minocycline, a commonly used antibiotic, will prevent pain. Minocycline blocks the activity of immune cells which the investigators believe are responsible for prolonging the pain.</brief_summary>
	<brief_title>Minocycline for the Prevention of Post-operative Intercostal Neuralgia</brief_title>
	<detailed_description>The study is of double-blind placebo controlled parallel groups design in up to 116 patients undergoing elective open thoracotomy. Minocycline 200mg twice daily or matching placebo are given three days before surgery.</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Male or female Aged 18 years or older Undertaking elective, open thoracotomy with ample time preoperatively to provide informed consent and undertake dosing Sufficient fluency in English language to read and understand consent form, fulfil study requirements and communicate with research staff Negative pregnancy test at screening for women of child bearing potential Females of child bearing potential must agree to use a medically acceptable method of contraception other than oral contraceptives from time of first dosing until one week postoperatively. Acceptable methods include abstinence, contraceptive patches, NuvaRing (etonogestrel/ethinyl oestradiol vaginal ring), diaphragm with vaginal spermicide, intrauterine device, condom and vaginal spermicide, progestin implant or injection Avoid prolonged, direct sunlight or ultraviolet light exposure during dosing period Refrain from strenuous activities and avoid changes to regular exercise patterns throughout trial period Pregnant or breast feeding Known allergy to minocycline and other tetracycline antibiotics Preexisting neuralgic pain condition in area designated for operation Physical abnormality in area designated for operation Taking disallowed concomitant medication Renal insufficiency as determined by a calculated creatinine clearance of &lt; 60mL/min Hepatic dysfunction as determined by alanine transaminase and/or aspartate transaminase in excess of three times upper normal limits Diagnosis of systemic lupus erythematosus Recent diagnosis of enterocolitis or colitis Participation in another trial of an investigational product within 30 days of commencing dosing or are scheduled to commence trial of an investigational product during study period Patients who, in an Investigator's opinion, should not participate in the trial or may not be capable of following the trial schedule for any reason History of major psychiatric disorder not medically controlled</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>Minocycline</keyword>
</DOC>